- $9.46bn
- $13.25bn
- $6.78bn
- 92
- 74
- 18
- 65
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 12.84 | ||
| PEG Ratio (f) | 0.63 | ||
| EPS Growth (f) | 25.39% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.55 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 14.19 | ||
| Price to Sales | 1.41 | ||
| EV to EBITDA | 8.93 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.47% | ||
| Return on Equity | 12.52% | ||
| Operating Margin | 16.12% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 6,393.6 | 7,386.1 | 7,512.4 | 6,967.2 | 6,783.6 | 6,685.18 | 6,916.28 | 2.35% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +97.82 | +2.84 | -29.75 | -2.63 | +47.25 | +10.94 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Directors
- Rajiv Gupta NEC (75)
- Michael Stubblefield PRE (48)
- Thomas Szlosek CFO (57)
- Meghan Henson CHO (51)
- Eric McAllister CHO (55)
- Michael Wondrasch EVP (52)
- Justin Miller EVP (54)
- James Bramwell EVP (54)
- Gerard Brophy EVP (55)
- Christophe Couturier EVP (55)
- Tanya Foxe EVP (48)
- Sven Henrichwark EVP (54)
- Sheri Lewis EVP (55)
- Mark Murray EVP (50)
- Devashish Ohri EVP (54)
- Frederic Vanderhaegen EVP (53)
- Steven Eck SVP (42)
- Tommy Thomas VPR
- Jonathan Peacock LED (63)
- Juan Andres IND (56)
- John Carethers IND (57)
- Matthew Holt IND (44)
- Lan Kang IND (52)
- Joseph Massaro IND (51)
- Mala Murthy IND (57)
- Michael Severino IND
- Christi Shaw IND (54)
- Gregory Summe IND (65)
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- May 3rd, 2017
- Public Since
- May 17th, 2019
- No. of Shareholders
- 6
- No. of Employees
- 13,500
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
New York Stock Exchange- Shares in Issue
- 681,429,663
- Address
- Building One, RADNOR, 19087
- Web
- https://www.avantorsciences.com/
- Phone
- +1 6103861700
- Contact
- Allison Hosak
- Auditors
- Deloitte & Touche LLP
Upcoming Events for AVTR
Q2 2025 Avantor Inc Earnings Release
Q3 2025 Avantor Inc Earnings Release
Similar to AVTR
Abbott Laboratories
New York Stock Exchange
Agilent Technologies
New York Stock Exchange
Alcon AG
New York Stock Exchange
Artivion
New York Stock Exchange
Avanos Medical
New York Stock Exchange
FAQ
What is the Avantor share price?
As of Today at 10:27 UTC, shares in Avantor are trading at $13.88. This share price information is delayed by 15 minutes.
How has the Avantor share price performed this year?
Shares in Avantor last closed at $13.88 and the price had moved by -33.94% over the past 365 days. In terms of relative price strength the Avantor share price has underperformed the S&P500 Index by -40.94% over the past year.
What are the analyst and broker recommendations for Avantor?
The overall consensus recommendation for Avantor is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Avantor dividend yield?
Avantor does not currently pay a dividend.
Does Avantor pay a dividend?
Avantor does not currently pay a dividend.
When does Avantor next pay dividends?
Avantor does not currently pay a dividend.
How do I buy Avantor shares?
To buy shares in Avantor you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Avantor?
As of the previous close price of $13.88, shares in Avantor had a market capitalisation of $9.46bn.
Where are Avantor shares listed?
Here are the trading details for Avantor:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: AVTR
What kind of share is Avantor?
Based on an overall assessment of its quality, value and momentum Avantor is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Avantor share price forecast for 2025?
The analyst consensus target price for shares in Avantor is $17.03. That is 22.69% above the last closing price of $13.88.
Analysts covering Avantor currently have a consensus Earnings Per Share (EPS) forecast of $1.02 for the next financial year.
Find out moreWhat is the trend in the Avantor share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Avantor. Over the past six months, its share price has underperformed the S&P500 Index by -38.79%.
As of the last closing price of $13.88, shares in Avantor were trading -26.14% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Avantor PE Ratio?
The Avantor PE ratio based on its reported earnings over the past 12 months is 12.84. The shares last closed at $13.88.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Avantor?
Avantor's management team is headed by:
- Rajiv Gupta - NEC
- Michael Stubblefield - PRE
- Thomas Szlosek - CFO
- Meghan Henson - CHO
- Eric McAllister - CHO
- Michael Wondrasch - EVP
- Justin Miller - EVP
- James Bramwell - EVP
- Gerard Brophy - EVP
- Christophe Couturier - EVP
- Tanya Foxe - EVP
- Sven Henrichwark - EVP
- Sheri Lewis - EVP
- Mark Murray - EVP
- Devashish Ohri - EVP
- Frederic Vanderhaegen - EVP
- Steven Eck - SVP
- Tommy Thomas - VPR
- Jonathan Peacock - LED
- Juan Andres - IND
- John Carethers - IND
- Matthew Holt - IND
- Lan Kang - IND
- Joseph Massaro - IND
- Mala Murthy - IND
- Michael Severino - IND
- Christi Shaw - IND
- Gregory Summe - IND